Page 104 - Programme book for The International Liver Congress 2015, EASL ILC 2015

SATURDAY, APRIL 25, 2015

Parallel Session: Viral Hepatitis B & D: Clinical (Cont.) Strauss 3

ABSTRACT PREDICTIVE VALUE OF BASELINE AND ON-TREATMENT
O116 QHBSAG LEVEL IN HBEAG POSITIVE CHB PATIENTS
12:30 - 12:45 WHO SWITCHED FROM NUCS TO PEGYLATED
INTERFERON A-2A: A FURTHER ANALYSIS FROM NEW
SCIENTIFIC PROGRAMME SWITH STUDY
Hong Ren, China

ABSTRACT PREDICTORS OF CLINICAL RESPONSE: RESULTS FROM
O117 A LARGE, RANDOMIZED CONTROLLED STUDY WITH
12:45 - 13:00 TENOFOVIR DISOPROXIL FUMARATE (TDF) PLUS
PEGINTERFERON ALFA-2A (PEG) COMBINATION FOR
CHRONIC HEPATITIS B (CHB)
Henry L. Chan, China

ABSTRACT OPTIMIZING THE PRENYLATION INHIBITOR
O118 LONAFARNIB USING RITONAVIR BOOSTING IN
13:00 - 13:15 PATIENTS WITH CHRONIC DELTA HEPATITIS
Cihan Yurdaydin, Turkey

ABSTRACT STOPPING TENOFOVIR DISOPROXIL FUMARATE
O119 (TDF) TREATMENT AFTER LONG TERM VIROLOGIC
13:15 - 13:30 SUPPRESSION IN HBEAG-NEGATIVE CHB: WEEK 48
INTERIM RESULTS FROM AN ONGOING RANDOMIZED,
CONTROLLED TRIAL («FINITE CHB»)
Thomas Berg, Germany

Joint Workshop: EASL-EFSUMB Lecture 2 Stolz 2
Ultrasound Guided Liver Biopsy: When and how to perform it

Chairs:
Christoph Dietrich, Germany
Massimo Pinzani, The United Kingdom

11:30 - 11:50 Pre-biopsy work-up: what the hepatologist should not miss
Robert de Knegt, The Netherlands

11:50 - 12:25 Biopsy Techniques and video demonstration
Christoph Dietrich, Germany

104 The International Liver Congress™ 2015 • ILC Programme